Emicizumab in the treatment of hemophilia A
Introduction: Despite substantial advances in the treatment of Hemophilia A with the use of concentrated factor VIII preparations during recent decades, bleeding episodes still occur from time to time. The development of inhibitors significantly reduces the efficacy of traditional replacement therap...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Medicinski fakultet i Klinika za stomatologiju, Niš
2020-01-01
|
Series: | Acta Stomatologica Naissi |
Subjects: | |
Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/0352-5252/2020/0352-52522081007T.pdf |